Left Ventricular Diastolic Dysfunction and Transcatheter Aortic Valve Replacement Outcomes: A Review
Overview
Affiliations
Aortic stenosis (AS) is the most common valvular disease that can lead to increased afterload, left ventricular (LV) remodeling, and myocardial fibrosis. We reviewed the literature addressing the impact of transcatheter aortic valve replacement (TAVR) on LV remodeling and patients' outcomes by elimination of AS-related high afterload. TAVR reduces afterload and improves LV remodeling recovery. However, myocardial fibrosis may not completely reverse after the TAVR. The LV diastolic dysfunction (LVDD) induced by AS is an independent predictor of post-TAVR mortality, and mortality increases with severity of LVDD. The impact of diastolic dysfunction on patient outcomes emerges at 30 days but continues to persist during mid-term follow-up. Based on severity of the baseline LVDD, some patients may tolerate post-TAVR aortic regurgitation (AR), but even minimal post-TAVR AR in patients with severe baseline LVDD can have an additive negative impact on survival. It is crucial to consider TAVR prior to development of advanced LVDD. Appropriate device selection and deployment technique are important in improvement of TAVR outcomes via elimination of AR.
Sonaglioni A, Nicolosi G, Bruno A, Lombardo M, Muti P J Clin Med. 2024; 13(21).
PMID: 39518435 PMC: 11546254. DOI: 10.3390/jcm13216296.
Dumitrof L, Nedelciuc I, Roca M, Crisan-Dabija R, Mihaescu T, Tinica G Medicina (Kaunas). 2022; 58(9).
PMID: 36143859 PMC: 9501961. DOI: 10.3390/medicina58091182.
Molecular Approaches and Echocardiographic Deformation Imaging in Detecting Myocardial Fibrosis.
Sonaglioni A, Nicolosi G, Rigamonti E, Lombardo M, La Sala L Int J Mol Sci. 2022; 23(18).
PMID: 36142856 PMC: 9501415. DOI: 10.3390/ijms231810944.
Ito K, Miyajima K, Urushida T, Unno K, Okazaki A, Takashima Y Ann Noninvasive Electrocardiol. 2022; 27(6):e13000.
PMID: 35972827 PMC: 9674782. DOI: 10.1111/anec.13000.
Twing A, Slostad B, Anderson C, Konda S, Groves E, Kansal M Am J Cardiovasc Dis. 2021; 11(2):203-211.
PMID: 34084655 PMC: 8166585.